ML030660382
| ML030660382 | |
| Person / Time | |
|---|---|
| Site: | Summer  |
| Issue date: | 03/06/2003 |
| From: | Cotton K NRC/NRR/DLPM/LPD2 |
| To: | Byrne S South Carolina Electric & Gas Co |
| References | |
| TAC MB4651 | |
| Download: ML030660382 (1) | |
Text
DEFINITIONS CONTAINMENT INTEGRITY 1.7 CONTAINMENT INTEGRITY shall exist when:
a All penetrations required to be closed during accident conditions are either:
- 1)
Capable of being closed by an OPERABLE containment automatic isolation valve system, or
- 2)
Closed by manual valves, blind flanges, or deactivated automatic valves secured in their closed positions, except for valves that are open under administrative control as permitted by Specification 3.6.4,
- b.
All equipment hatches are closed and sealed,
- c.
Each air lock is in compliance with the requirements of Specification 3.6.1.3,
- d.
The containment leakage rates are within the limits of Specification 6.8.4.g, and
- e.
The sealing mechanism associated with each penetration (e.g., welds, bellows, or O-rings) is OPERABLE.
CONTROLLED LEAKAGE 1.8 CONTROLLED LEAKAGE shall be that seal water flow supplied to the reactor coolant pump seals.
CORE ALTERATION 1.9 CORE ALTERATION shall be the movement of any fuel, sources, or reactivity control components within the reactor pressure vessel with the vessel head removed and fuel in the vessel. Suspension of CORE ALTERATION shall not preclude completion of movement of a component to a safe position.
CORE OPERATING LIMITS REPORT 1.9a The CORE OPERATING LIMITS REPORT (COLR) is the unit specific document that provides core operating limits for the current operating reload cycle. The cycle specific core operating limits shall be determined for each reload cycle in accordance with Specification 6.9.1.11. Plant operation within these operating limits is addressed in individual specifications.
DOSE EQUIVALENT 1-131 1.10 DOSE EQUIVALENT 1-131 shall be that concentration of 1-131 (microcurie/gram) which alone would produce the same thyroid dose as the quantity and isotopic mixture of 1-131, 1-132, 1-133, 1-134, and 1-135 actually present. The thyroid dose conversion factors used for this calculation shall be those listed in ICRP 30, Supplement to Part I, pages 192-212, Table titled, "Committed Dose Equivalent in Target Organs or Tissues per Intake of Unit Activity."
Amendment No. 88, 110, 135, 138, 162 1-2 SUMMER - UNIT 1